• Most Popular
  • Most Shared

Abraxis says FDA OKs generic equivalent of Pfizer's injection

Thu May 10, 2007 4:06pm EDT

Stocks

   

Regulatory News

May 10 (Reuters) - Abraxis BioScience Inc. ABBI.O said it received approvals from the U.S. Food and Drug Administration to market several strengths of clindamycin injection, a generic version of Pfizer Inc.'s (PFE.N) Cleocin Phosphate injection.

The biopharmaceutical company said sales of clindamycin, used to treat serious infections, exceeded $16 million in the United States in 2006.

(Reporting by Amitha Rajan in Bangalore)

((Editing by Varsha Tickoo; Reuters Messaging: amitha.rajan.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91-80-4135-5800)) Keywords: ABRAXISBIOSCIENCE FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS1075
Regulatory News


More from Reuters

Photo

Senate on verge of passing healthcare bill

WASHINGTON (Reuters) - Senate Democrats cleared the last 60-vote hurdle on President Barack Obama's healthcare overhaul on Wednesday, virtually ensuring final passage of its version of the biggest health policy changes in four decades.

» More Top News
An Iranian woman supporting former prime Mmnister Mirhossein Mousavi, who is a candidate for the upcoming presidential elections, covers her face with his picture during a pre-election gathering at a stadium in Tehran June 9, 2009. REUTERS/Damir Sagolj

A nation on the brink?

Nukes may not be the only ticking clock in Iran. The reformist movement is swelling and "it is going to get very violent."  Full Article 

Iran
A security guard walks past cars in a Geely Automobile Holdings Ltd. factory in a Shanghai suburb September 28, 2006.REUTERS/Aly Song
WEI GU:

China in auto power play

It might not shake up the industry just yet, but China's interest in Volvo and Saab is the start of something big in global autos.  Commentary | Video 

CHINA